Browse > Article
http://dx.doi.org/10.5483/BMBRep.2020.53.6.054

Regulation of signal transducer and activator of transcription 3 activation by dual-specificity phosphatase 3  

Kim, Ba Reum (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University)
Ha, Jain (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University)
Kang, Eunjeong (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University)
Cho, Sayeon (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University)
Publication Information
BMB Reports / v.53, no.6, 2020 , pp. 335-340 More about this Journal
Abstract
Since cancer is the leading cause of death worldwide, there is an urgent need to understand the mechanisms underlying cancer progression and the development of cancer inhibitors. Signal transducer and activator of transcription 3 (STAT3) is a major transcription factor that regulates the proliferation and survival of various cancer cells. Here, dual-specificity phosphatase 3 (DUSP3) was identified as a regulator of STAT3 based on an interaction screening performed using the protein tyrosine phosphatase library. DUSP3 interacted with the C-terminal domain of STAT3 and dephosphorylated p-Y705 of STAT3. In vitro dephosphorylation assay revealed that DUSP3 directly dephosphorylated p-STAT3. The suppressive effects of DUSP3 on STAT3 were evaluated by a decreased STAT3-specific promoter activity, which in turn reduced the expression of the downstream target genes of STAT3. In summary, DUSP3 downregulated the transcriptional activity of STAT3 via dephosphorylation at Y705 and also suppressed the migratory activity of cancer cells. This study demonstrated that DUSP3 inhibits interleukin 6 (IL-6)/STAT3 signaling and is expected to regulate cancer development. Novel functions of DUSP3 discovered in IL-6/STAT3 signaling regulation would help expand the understanding of cancer development mechanisms.
Keywords
Dephosphorylation; Dual-specificity phosphatase 3; Protein tyrosine phosphatase; Signal transducer and activator of transcription 3; Signal transduction;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Han Y, Amin HM, Franko B, Frantz C, Shi X and Lai R (2006) Loss of SHP1 Enhances JAK3/STAT3 Signaling and Decreases Proteosome Degradation of JAK3 and NPM-ALK in ALK+ Anaplastic Large-Cell Lymphoma. Blood 108, 2796-2803
2 Li C and Friedman JM (1999) Leptin Receptor Activation of SH2 Domain Containing Protein Tyrosine Phosphatase 2 Modulates Ob Receptor SignalTtransduction. Proc Natl Acad Sci U S A 96, 9677-9682   DOI
3 Wakahara R, Kunimoto H, Tanino K et al (2012) Phospho-Ser727 of STAT3 Regulates STAT3 Activity by Enhancing Dephosphorylation of Phospho-Tyr705 Largely through TC45. Genes Cells 17, 132-145   DOI
4 Veeriah S, Brennan C, Meng S et al (2009) The Tyrosine Phosphatase PTPRD is a Tumor Suppressor that is Frequently Inactivated and Mutated in Glioblastoma and Other Human Cancers. Proc Natl Acad Sci U S A 106, 9435-9440   DOI
5 Zhang X, Guo A, Yu J et al (2007) Identification of STAT3 as a Substrate of Receptor Protein Tyrosine Phosphatase T. Proc Natl Acad Sci U S A 104, 4060-4064   DOI
6 Chen YW, Guo T, Shen L et al (2015) Receptor-Type Tyrosine-Protein Phosphatase Kappa Directly Targets STAT3 Activation for Tumor Suppression in Nasal NK/T-Cell Lymphoma. Blood 125, 1589-1600   DOI
7 Alonso A, Sasin J, Bottini N et al (2004) Protein tyrosine phosphatases in the human genome. Cell 117, 699-711   DOI
8 Bourdeau A, Dube N and Tremblay ML (2005) Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 17, 203-209   DOI
9 Pavic K, Duan G and Kohn M (2015) VHR/DUSP3 Phosphatase: Structure, Function and Regulation. FEBS J 282, 1871-1890   DOI
10 Lee H, Morales LD, Slaga TJ and Kim DJ (2015) Activation of T-cell protein-tyrosine phosphatase suppresses keratinocyte survival and proliferation following UVB irradiation. J Biol Chem 290, 13-24   DOI
11 Vandereyken M, Jacques S, Van Overmeire E et al (2017) Dusp3 Deletion in Mice Promotes Experimental Lung Tumour Metastasis in a Macrophage Dependent Manner. PLoS One 12, e0185786   DOI
12 Singh P, Dejager L, Amand M et al (2015) DUSP3 Genetic Deletion Confers M2-Like Macrophage-Dependent Tolerance to Septic Shock. J Immunol 194, 4951-4962   DOI
13 Takaishi K, Komohara Y, Tashiro H et al (2010) Involvement of M2-Polarized Macrophages in the Ascites from Advanced Epithelial Ovarian Carcinoma in Tumor Progression via Stat3 Activation. Cancer Sci 101, 2128-2136   DOI
14 Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H and Takeya M (2012) Glucagon-Like Peptide-1 (GLP-1) Induces M2 Polarization of Human Macrophages via STAT3 Activation. Biochem Biophys Res Commun 425, 304-308   DOI
15 Park Y and Kim J (2019) Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells. BMB Rep 52, 214-219   DOI
16 Perovic V, Sumonja N, Gemovic B, Toska E, Roberts SG and Veljkovic N (2017) TRI_Tool: a Web-Tool for Prediction of Protein-Protein Interactions in Human Transcriptional Regulation. Bioinformatics 33, 289-291   DOI
17 Multhoff G, Molls M and Radons J (2011) Chronic Inflammation in Cancer Development. Front Immunol 2, Article 98
18 DeNardo DG, Johansson M and Coussens LM (2008) Immune Cells as Mediators of Solid Tumor Metastasis. Cancer Metastasis Rev 27, 11-18   DOI
19 Lee H, Jeong AJ and Ye SK (2019) Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep 52, 415-423   DOI
20 Darnell JE (1997) STATs and Gene Regulation. Science 277, 1630-1635   DOI
21 Inoue H, Ogawa W, Ozaki M et al (2004) Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10, 168-174   DOI
22 Yu H and Jove R (2004) The STATs of Cancer-New Molecular Targets Come of Age. Nat Rev Cancer 4, 97-105   DOI
23 Demaria M, Giorgi C, Lebiedzinska M et al (2010) A STAT3-Mediated Metabolic Switch is Involved in Tumour Transformation and STAT3 Addiction. Aging (Albany NY) 2, 823-842   DOI
24 Li J, Liu T, Zhao L et al (2015) Ginsenoside 20 (S)-Rg3 Inhibits the Warburg Effect through STAT3 Pathways in Ovarian Cancer Cells. Int J Oncol 46, 775-781   DOI
25 Ishibashi T, Bottaro DP, Chan A, Miki T and Aaronson SA (1992) Expression Cloning of a Human Dual-Specificity Phosphatase. Proc Natl Acad Sci U S A 89, 12170-12174   DOI
26 Svinka J, Mikulits W and Eferl R (2014) STAT3 in hepatocellular carcinoma: new perspectives. Hepat Oncol 1, 107-120   DOI
27 Lee S, Lee M, Kim JB et al (2016) 17beta-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Biochem Biophys Res Commun 473, 1247-1254   DOI
28 Kim M, Morales L, Jang IS, Cho YY and Kim D (2018) Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling. Int J Mol Sci 19, E2708
29 Sekine Y, Tsuji S, Ikeda O et al (2006) Regulation of STAT3-Mediated Signaling by LMW-DSP2. Oncogene 25, 5801-5806   DOI
30 Hou J, Xu J, Jiang R et al (2013) Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology 57, 678-688   DOI
31 Wang JY, Yeh CL, Chou HC et al (2011) Vaccinia H1-Related Phosphatase (VHR) is a Phosphatase of ErbB Receptors and is Down-Regulated in Non-Small Cell lung Cancer. J Biol Chem 286, 10177-10184   DOI
32 Todd JL, Rigas JD, Rafty LA and Denu JM (2002) Dual-Specificity Protein Tyrosine Phosphatase VHR Down-Regulates c-Jun N-terminal Kinase (JNK). Oncogene 21, 2573-2583   DOI
33 Kumar J, Fraser F, Riley C, Ahmed N, McCulloch D and Ward A (2015) Granulocyte Colony-Stimulating Factor Receptor Signalling via Janus Kinase 2/Signal Transducer and Activator of Transcription 3 in Ovarian Cancer. Br J Cancer 113, 1642-1643
34 Todd JL, Tanner KG and Denu JM (1999) Extracellular Regulated Kinases (ERK) 1 and ERK2 are Authentic Substrates for the Dual-Specificity Protein-Tyrosine Phosphatase VHR. A Aovel Role in Down-Regulating the ERK Pathway. J Biol Chem 274, 13271-13280   DOI
35 Liu L, McBride KM and Reich NC (2005) STAT3 Nuclear Import is Independent of Tyrosine Phosphorylation and Mediated by Importin-${\alpha}3$. Proc Natl Acad Sci U S A 102, 8150-8155   DOI
36 Bromberg J and Wang TC (2009) Inflammation and Cancer: IL-6 and STAT3 Complete the Link. Cancer Cell 15, 79-80   DOI
37 Stahl N, Boulton TG, Farruggella T et al (1994) Association and Activation of Jak-Tyk Kinases by CNTF-LIFOSM- IL-6 Beta Receptor Components. Science 263, 92-95   DOI
38 Puente XS, Pinyol M, Quesada V et al (2011) Whole-Genome Sequencing Identifies Recurrent Mutations in Chronic Lymphocytic Leukaemia. Nature 475, 101-105   DOI
39 Devarajan E and Huang S (2009) STAT3 as a Central Regulator of Tumor Metastases. Curr Mol Med 9, 626-633   DOI
40 Hoyt R, Zhu W, Cerignoli F, Alonso A, Mustelin T and David M (2007) Cutting Edge: Selective Tyrosine Dephosphorylation of Interferon-Activated Nuclear STAT5 by the VHR Phosphatase. J Immunol 179, 3402-3406   DOI